Talkspace leaders depart as company’s growth falls short of expectations
The company’s co-founders are leaving the company as it struggles with retention and billing, with revenue coming short of expectations for the quarter. In the […]
The company’s co-founders are leaving the company as it struggles with retention and billing, with revenue coming short of expectations for the quarter. In the […]
Shots: EMA’s CHMP has recommended conditional marketing authorization of Selumetinib in the EU. The recommendation is based on the results from the P-I/II SPRINT Stratum […]
Digital primary care startup 98point6 is adding digital mental health services to its app. The company added text-based visits with a therapist or behavioral health […]
Shots: The approval follows P-III ORIENT-11 study assessing Tyvyt (sintilimab) vs PBO + Almita (pemetrexed) and platinum CT in 397 participants in a ratio (2:1) […]
Shots: Janssen acquires rights to Hemera’s HMR59, administered as a one-time, outpatient, IVT inj. to help preserve vision in patients with geographic atrophy The acquisition […]
Shots: This BT designation is based on P-IIb/III HPTN 083 study assessing cabotegravir (q8w) vs. FTC/TDF tablets (qd PO, 200/300 mg) in a study population […]
Shots: The P-II trial will assess BI 764198 (qd for ~4wks.) in patients hospitalized for COVID-19 with expected enrollment initiation in Oct’2020. The 1EPs will […]
Shots: The P-I dose-escalation study will assess the safety, tolerability, and preliminary efficacy of DS-1055 in adult patients with r/r advanced or metastatic head and […]
Copyright © 2024 | WordPress Theme by MH Themes